{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T07:10:38Z","timestamp":1787901038819,"version":"build-2784847793"},"reference-count":30,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,4,13]],"date-time":"2021-04-13T00:00:00Z","timestamp":1618272000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000009","name":"Foundation for the National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000009","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Controlled Release"],"published-print":{"date-parts":[[2021,6]]},"DOI":"10.1016\/j.jconrel.2021.04.009","type":"journal-article","created":{"date-parts":[[2021,4,16]],"date-time":"2021-04-16T18:55:41Z","timestamp":1618599341000},"page":"106-113","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"special_numbering":"C","title":["Advanced genetic engineering to achieve in vivo targeting of adenovirus utilizing camelid single domain antibody"],"prefix":"10.1016","volume":"334","author":[{"given":"Myungeun","family":"Lee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhi Hong","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles B.","family":"Shoemaker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacqueline M.","family":"Tremblay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bradley","family":"St. Croix","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven","family":"Seaman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebeca","family":"Gonzalez-Pastor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena A.","family":"Kashentseva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Igor P.","family":"Dmitriev","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David T.","family":"Curiel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jconrel.2021.04.009_bb0005","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1089\/hum.2013.2527","article-title":"Adenovirus: the first effective in vivo gene delivery vector","volume":"25","author":"Crystal","year":"2014","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.jconrel.2021.04.009_bb0010","doi-asserted-by":"crossref","first-page":"421","DOI":"10.2174\/1566523213666131125095046","article-title":"Adenovirus vectors for gene therapy, vaccination and cancer gene therapy","volume":"13","author":"Wold","year":"2013","journal-title":"Curr. Gene Ther."},{"key":"10.1016\/j.jconrel.2021.04.009_bb0015","first-page":"700","article-title":"Viral vectors for gene therapy: current state and clinical perspectives","volume":"81","author":"Lukashev","year":"2016","journal-title":"Biochemistry"},{"key":"10.1016\/j.jconrel.2021.04.009_bb0020","doi-asserted-by":"crossref","first-page":"3609","DOI":"10.1002\/1873-3468.13691","article-title":"State-of-the-art human adenovirus vectorology for therapeutic approaches","volume":"593","author":"Gao","year":"2019","journal-title":"FEBS Lett."},{"key":"10.1016\/j.jconrel.2021.04.009_bb0025","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1111\/cts.12466","article-title":"Gene therapy 2017: progress and future directions","volume":"10","author":"Keeler","year":"2017","journal-title":"Clin. Transl. Sci."},{"key":"10.1016\/j.jconrel.2021.04.009_bb0030","doi-asserted-by":"crossref","first-page":"2536","DOI":"10.1158\/1535-7163.MCT-10-0332","article-title":"Substitution of adenovirus serotype 3 hexon onto a serotype 5 oncolytic adenovirus reduces factor X binding, decreases liver tropism, and improves antitumor efficacy","volume":"9","author":"Short","year":"2010","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.jconrel.2021.04.009_bb0035","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1158\/1535-7163.MCT-19-0768","article-title":"Targeting tumor neoangiogenesis via targeted adenoviral vector to achieve effective cancer gene therapy for disseminated neoplastic disease","volume":"19","author":"Lee","year":"2020","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.jconrel.2021.04.009_bb0040","doi-asserted-by":"crossref","first-page":"7438","DOI":"10.1038\/s41598-017-07457-5","article-title":"A camelid single-domain antibody neutralizes botulinum neurotoxin A by blocking host receptor binding","volume":"7","author":"Yao","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jconrel.2021.04.009_bb0045","doi-asserted-by":"crossref","first-page":"e12","DOI":"10.1016\/j.wneu.2019.10.044","article-title":"Expression and clinical significance of immune checkpoint regulator B7-H3 (CD276) in human meningioma","volume":"135","author":"Deng","year":"2020","journal-title":"World Neurosurg."},{"key":"10.1016\/j.jconrel.2021.04.009_bb0050","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0216825","article-title":"CD276 and the gene signature composed of GATA3 and LGALS3 enable prognosis prediction of glioblastoma multiforme","volume":"14","author":"Takashima","year":"2019","journal-title":"PLoS One"},{"key":"10.1016\/j.jconrel.2021.04.009_bb0055","doi-asserted-by":"crossref","DOI":"10.3390\/jcm7070172","article-title":"Tumor B7-H3 (CD276) expression and survival in pancreatic cancer","volume":"7","author":"Inamura","year":"2018","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.jconrel.2021.04.009_bb0060","doi-asserted-by":"crossref","first-page":"2697","DOI":"10.1111\/cas.13744","article-title":"Genetic and clinical characterization of B7-H3 (CD276) expression and epigenetic regulation in diffuse brain glioma","volume":"109","author":"Wang","year":"2018","journal-title":"Cancer Sci."},{"key":"10.1016\/j.jconrel.2021.04.009_bb0065","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.virol.2013.09.020","article-title":"Retargeting of gene expression using endothelium specific hexon modified adenoviral vector","volume":"447","author":"Kaliberov","year":"2013","journal-title":"Virology"},{"key":"10.1016\/j.jconrel.2021.04.009_bb0070","doi-asserted-by":"crossref","first-page":"4176","DOI":"10.1128\/JVI.75.9.4176-4183.2001","article-title":"Genetic targeting of an adenovirus vector via replacement of the fiber protein with the phage T4 fibritin","volume":"75","author":"Krasnykh","year":"2001","journal-title":"J. Virol."},{"key":"10.1016\/j.jconrel.2021.04.009_bb0075","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1038\/labinvest.2014.82","article-title":"Adenoviral targeting using genetically incorporated camelid single variable domains","volume":"94","author":"Kaliberov","year":"2014","journal-title":"Lab. Investig."},{"key":"10.1016\/j.jconrel.2021.04.009_bb0080","doi-asserted-by":"crossref","first-page":"15001","DOI":"10.1038\/mto.2015.1","article-title":"Retargeted oncolytic adenovirus displaying a single variable domain of camelid heavy-chain-only antibody in a fiber protein","volume":"2","author":"van Erp","year":"2015","journal-title":"Mol. Ther. Oncol."},{"key":"10.1016\/j.jconrel.2021.04.009_bb0085","doi-asserted-by":"crossref","first-page":"2560","DOI":"10.1158\/1078-0432.CCR-18-0432","article-title":"CAR T cells targeting B7-H3, a pan-cancer antigen, demonstrate potent preclinical activity against pediatric solid tumors and brain tumors","volume":"25","author":"Majzner","year":"2019","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.jconrel.2021.04.009_bb0090","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/j.ccell.2017.03.005","article-title":"Eradication of tumors through simultaneous ablation of CD276\/B7-H3-positive tumor cells and tumor vasculature","volume":"31","author":"Seaman","year":"2017","journal-title":"Cancer Cell"},{"key":"10.1016\/j.jconrel.2021.04.009_bb0095","doi-asserted-by":"crossref","first-page":"3523","DOI":"10.1007\/s00705-017-3513-z","article-title":"Virus purification by CsCl density gradient using general centrifugation","volume":"162","author":"Nasukawa","year":"2017","journal-title":"Arch. Virol."},{"key":"10.1016\/j.jconrel.2021.04.009_bb0100","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0052326","article-title":"Microparticle-mediated transfer of the viral receptors CAR and CD46, and the CFTR channel in a CHO cell model confers new functions to target cells","volume":"7","author":"Gonzalez","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.jconrel.2021.04.009_bb0105","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00705-002-0911-6","article-title":"Gene transfer by adenovirus-mimetic peptides in the presence of a cationic lipid and\/or adenovirus. Analysis of the contribution of the viral and nonviral components","volume":"148","author":"Moritz","year":"2003","journal-title":"Arch. Virol."},{"key":"10.1016\/j.jconrel.2021.04.009_bb0110","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/j.ygyno.2005.08.042","article-title":"Ovarian cancer targeted adenoviral-mediated mda-7\/IL-24 gene therapy","volume":"100","author":"Mahasreshti","year":"2006","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.jconrel.2021.04.009_bb0115","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1097\/IGC.0000000000000664","article-title":"Heated IntraPEritoneal chemotherapy (HIPEC) for patients with recurrent ovarian cancer: a systematic literature review","volume":"26","author":"Hotouras","year":"2016","journal-title":"Int. J. Gynecol. Cancer"},{"key":"10.1016\/j.jconrel.2021.04.009_bb0120","article-title":"Understanding and addressing barriers to successful adenovirus-based virotherapy for ovarian cancer","author":"Gonzalez-Pastor","year":"2020","journal-title":"Cancer Gene Ther."},{"key":"10.1016\/j.jconrel.2021.04.009_bb0125","doi-asserted-by":"crossref","DOI":"10.2310\/7290.2014.00024","article-title":"Monitoring of biodistribution and persistence of conditionally replicative adenovirus in a murine model of ovarian cancer using capsid-incorporated mCherry and expression of human somatostatin receptor subtype 2 gene","volume":"13","author":"Dmitriev","year":"2014","journal-title":"Mol. Imag."},{"key":"10.1016\/j.jconrel.2021.04.009_bb0130","doi-asserted-by":"crossref","first-page":"4805","DOI":"10.1128\/jvi.70.7.4805-4810.1996","article-title":"Efficient generation of recombinant adenovirus vectors by homologous recombination in Escherichia coli","volume":"70","author":"Chartier","year":"1996","journal-title":"J. Virol."},{"key":"10.1016\/j.jconrel.2021.04.009_bb0135","first-page":"223","article-title":"Preparation and titration of CsCl-banded adenovirus stocks","volume":"130","author":"Tollefson","year":"2007","journal-title":"Methods Mol. Med."},{"key":"10.1016\/j.jconrel.2021.04.009_bb0140","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1006\/viro.2002.1406","article-title":"Evaluation of accuracy and precision of adenovirus absorptivity at 260 nm under conditions of complete DNA disruption","volume":"295","author":"Sweeney","year":"2002","journal-title":"Virology"},{"key":"10.1016\/j.jconrel.2021.04.009_bb0145","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1038\/labinvest.2014.78","article-title":"The myeloid-binding peptide adenoviral vector enables multi-organ vascular endothelial gene targeting","volume":"94","author":"Lu","year":"2014","journal-title":"Lab. Investig."},{"key":"10.1016\/j.jconrel.2021.04.009_bb0150","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.00265-20","article-title":"A new gorilla adenoviral vector with natural lung tropism avoids liver toxicity and is amenable to capsid engineering and vector retargeting","volume":"94","author":"Lu","year":"2020","journal-title":"J. Virol."}],"container-title":["Journal of Controlled Release"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365921001759?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365921001759?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T15:57:08Z","timestamp":1759161428000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168365921001759"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6]]},"references-count":30,"alternative-id":["S0168365921001759"],"URL":"https:\/\/doi.org\/10.1016\/j.jconrel.2021.04.009","relation":{},"ISSN":["0168-3659"],"issn-type":[{"value":"0168-3659","type":"print"}],"subject":[],"published":{"date-parts":[[2021,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Advanced genetic engineering to achieve in vivo targeting of adenovirus utilizing camelid single domain antibody","name":"articletitle","label":"Article Title"},{"value":"Journal of Controlled Release","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jconrel.2021.04.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}